Navigation Links
Proove Biosciences Will Be Exhibiting I.M.P.L.O.R.E Study at the American Academy of Pain Management 25th Annual Meeting
Date:9/23/2014

IRVINE, CA and ANNAPOLIS JUNCTION, MD (PRWEB) September 23, 2014

Proove Biosciences, the commercial and research leader in personalized medicine, presented industry leading research and data on the association between gender and opioid misuse this past weekend at the American Academy of Pain Management’ s 25th annual Clinical Meeting. The meeting took place in Phoenix, Arizona at the

Proove Biosciences presented their proprietary study on the linkage between gender and genetic predisposition to opioid misuse risk in chronic pain patients. Proove Biosciences’ very own Dr. Derrick Holman presented the research, titled the I.M.P.L.O.R.E Study (Investigation Measuring Predictive Levels of Opioid Risk by Evaluating Genotype versus Common Screening Tools). Proove Biosciences has been presenting research and data at major industry conferences and events over the last two years.

This year’s annual meeting offers attendees and industry practitioners engaging presentations by leading researchers and experts in the field of integrative pain management. The conference aims to address the benefits of using an integrative model of care to manage pain, as well as explain how research is supporting integrative pain management techniques. Additionally, the conference will feature insight on how to assess pain using a variety of strategies, and how to create treatment plans for patients with chronic pain that incorporate lifestyle and mind-body therapies.

“Our research has garnered significant attention from pain medicine and addiction professionals because they understand the importance of genetic variables in determining the most effective treatments for their patients,” stated Brian Meshkin, President of Proove Biosciences. “The I.M.P.L.O.R.E. Study was an investigation involving 1,629 chronic pain patients who were genotyped using Proove’s proprietary Narcotic Risk Profile. This observation study will help us better understand the link between addiction, treatment, and gender. We are excited to share our findings with the professionals at the American Academy of Pain Management’s 25th annual meeting, and look forward demonstrating how our genetic testing has been helping physicians better understand the individual variables associated with pain and pain treatment.”

About Proove Biosciences

Our mission is to change the future of medicine by providing proof to improve healthcare decisions. We envision a future when clinicians will know how patients are likely to respond to medications before writing a prescription. We believe genetic testing can provide such knowledge. Using a simple cheek swab, Proove performs proprietary genetic tests in its CLIA-certified laboratory. Healthcare providers use the results to evaluate how their patients will metabolize medications, and to screen for the likelihood of medication misuse.

Founded in 2009 with offices in Southern California and the Baltimore-Washington metropolitan area, Proove Biosciences is the leader in genetics-related personalized pain medicine research with hundreds of clinical research sites across the U.S. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).

Read the full story at http://www.prweb.com/releases/2014/09/prweb12191640.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
4. Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree
5. Proove Biosciences Will Be Exhibiting At The 2013 Common Sense Pain Management Conference
6. Proove Biosciences to Present Research on the Genetics of Pain Medicine and Exhibit at ASRA’s 12th Annual Pain Medicine Meeting
7. Proove Biosciences Will Be Exhibiting at the National Workers Compensation Conference and Expo on November 20-22
8. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
9. Proove Biosciences Successfully Presents Data and Exhibits at the Eastern Pain Association’s Annual Meeting in New York, New York
10. Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting
11. Proove Biosciences Exhibits Industry Leading Data and Research at PAINWeek 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in ... 8:30aET on RFD-TV. , With global population estimates nearing ten billion people by ... feed a growing nation. At the same time, many of our valuable resources are ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface electromyography (sEMG) ... tonic-clonic seizures (GTCS) using surface electromyography (sEMG). The prospective multicenter phase III ...
(Date:10/7/2017)... , Oct. 6, 2017  The 2017 Nobel ... three scientists, Jacques Dubochet, Joachim Frank ... in cryo-electron microscopy (cryo-EM) have helped ... the structural biology community. The winners worked with ... now routinely produce highly resolved, three-dimensional images of ...
(Date:10/5/2017)... ... , ... LabRoots , the leading provider of educational and interactive virtual ... to cancer research with a month-long promotion supporting the advancement of breast cancer research ... use promo code PinkRibbon to get 10 percent off their purchase of every the ...
Breaking Biology Technology:
(Date:7/20/2017)... Delta (NYSE: DAL ) customers now can use ... Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan Washington ... Delta,s biometric boarding pass experience that ... integrated into the boarding process to allow eligible Delta SkyMiles Members who ...
(Date:6/14/2017)... June 15, 2017  IBM (NYSE: IBM ) is introducing ... event dedicated to developing collaboration between startups and global businesses, ... 15-17. During the event, nine startups will showcase the solutions ... various industries. France ... market, with a 30 percent increase in the number of ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
Breaking Biology News(10 mins):